UCHEALTH PIKES PEAK REGIONAL HOSPITAL

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$88,333	$70,666	—	—	32
C1874	HB OR-IMPL AORTIC ENDOPROSTH THOR (43)	$72,103	$57,683	—	—	32
J9229	INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN	$53,337	$42,669	—	—	32
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$48,058	$38,447	—	—	26
C1786	HB OR-IMPL PACEMAKER (36)	$44,063	$35,250	—	—	32
J2997	ALTEPLASE 100 MG INTRAVENOUS SOLUTION	$38,326	$30,661	—	—	32
C1767	HB OR-IMPL PAIN GEN/STIMULATOR (33)	$36,052	$28,841	—	—	26
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$35,203	$28,162	—	—	32
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$33,431	$26,745	—	—	32
J9325	TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION	$33,319	$26,655	—	—	43
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$28,548	$22,838	—	—	26
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$27,461	$21,969	—	—	26
J9144	DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN	$24,491	$19,593	—	—	26
0278	HB OR-IMPL BONE MATRIX (25)	$20,029	$16,023	—	—	43
C1771	HB OR-IMPL SLING GRAFT (25)	$20,029	$16,023	—	—	32
J2323	NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION	$19,978	$15,983	—	—	32
J2353	OCTREOTIDE,MICROSPHERES ER 20 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE	$19,501	$15,601	—	—	32
J9312	RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS	$18,951	$15,161	—	—	32
J9299	NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION	$18,131	$14,505	—	—	32
J9271	PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION	$17,781	$14,225	—	—	32
J3101	TENECTEPLASE 50 MG INTRAVENOUS SOLUTION (FOR STEMI)	$17,726	$14,181	—	—	32
J0517	BENRALIZUMAB 30 MG/ML SUBCUTANEOUS AUTO-INJECTOR	$17,628	$14,102	—	—	38
J9352	TRABECTEDIN 1 MG INTRAVENOUS SOLUTION	$17,510	$14,008	—	—	32
J9307	PRALATREXATE 20 MG/ML (1 ML) INTRAVENOUS SOLUTION	$17,252	$13,802	—	—	38
C1768	HB OR-IMPL PERIPH VASCULAR GRAFT (23)	$16,023	$12,818	—	—	32
J9306	PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION	$15,880	$12,704	—	—	43
J1303	RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION	$15,285	$12,228	—	—	32
J9204	MOGAMULIZUMAB-KPKC 4 MG/ML INTRAVENOUS SOLUTION	$14,207	$11,365	—	—	26
J9330	TEMSIROLIMUS 30 MG/3 ML (10 MG/ML) (FIRST DILUTION) INTRAVENOUS SOLN	$13,578	$10,863	—	—	26
J9354	ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION	$12,028	$9,623	—	—	20
J9356	TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION	$11,981	$9,585	—	—	32
Q5127	PEGFILGRASTIM-FPGK 6 MG/0.6 ML SUBCUTANEOUS SYRINGE	$11,777	$9,422	—	—	20
J9305	PEMETREXED DISODIUM 500 MG INTRAVENOUS POWDER FOR SOLUTION	$11,185	$8,948	—	—	26
Q5120	PEGFILGRASTIM-BMEZ 6 MG/0.6 ML SUBCUTANEOUS SYRINGE	$10,978	$8,783	—	—	43
Q5107	BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION	$10,939	$8,751	—	—	64
J9047	CARFILZOMIB 60 MG INTRAVENOUS SOLUTION	$10,663	$8,530	—	—	32
C1874	HB OR-IMPL VASC STENT (19)	$10,633	$8,506	—	—	43
C1877	HB OR-IMPL VASC STENT NONCOAT (19)	$10,633	$8,506	—	—	38
Q5146	TRASTUZUMAB-STRF 420 MG INTRAVENOUS SOLUTION	$10,488	$8,390	—	—	32
Q5111	PEGFILGRASTIM-CBQV 6 MG/0.6 ML (DELIVERABLE) WEARABLE SUBCUT INJECTOR	$10,247	$8,198	—	—	32
Q5111	PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE	$9,818	$7,854	—	—	38
J9319	ROMIDEPSIN 10 MG/2 ML INTRAVENOUS POWDER FOR SOLUTION	$9,643	$7,715	—	—	20
J9034	BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION	$9,481	$7,585	—	—	43
J2182	MEPOLIZUMAB 100 MG SUBCUTANEOUS SOLUTION	$9,211	$7,369	—	—	38
26951	HB AMPUTATION FNGR/THUMB W/ DIR CLSE	$9,170	$7,336	—	—	20
L8612	HB OR-IMPL OPTHALMIC SHUNT (17)	$9,116	$7,293	—	—	26
J0897	DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION	$9,066	$7,253	—	—	32
78492	HB RADIANT MYO PERF MULT-REST/STRESS (PET)	$9,007	$7,206	—	—	32
J9205	IRINOTECAN LIPOSOMAL 4.3 MG/ML INTRAVENOUS	$8,981	$7,185	—	—	32
Q5136	DENOSUMAB-BBDZ 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION	$8,875	$7,100	—	—	32

Showing top 50 of 17,456 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.